Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

NCT ID: NCT06885203

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-27

Study Completion Date

2029-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors.

A community-based and peer-led Black Breast Cancer Survivor's Intervention (BBCSI) course has been developed to help improve the quality of life of Black breast cancer survivors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objectives:

Guided by the Transcreation Framework for Community-engaged Behavioral Interventions to Reduce Health Disparities (Transcreation Framework), the overall purpose of this study is to determine the feasibility, acceptability, and preliminary efficacy of the proposed biobehavioral community-based and peer-led Black Breast Cancer Survivors Intervention (BBCSI) to improve QOL. To achieve this goal, I have assembled a strong mentorship team with complementary and relevant expertise to pursue the following specific aims:

Specific Aim 1: Develop a prototype of the BBCSI curriculum and assess satisfaction of the intervention. In partnership with two community-based organizations in Georgia and California; and guided by the Transcreation Framework, a prototype of the intervention and associated materials will be developed. Satisfaction of the content, materials, and intervention delivery procedures will be assessed through key informant interviews with Black breast cancer survivors (within two-years of diagnosis) and community interventionists.

Specific Aim 2: Determine the preliminary efficacy of the BBCSI. Using a one group, pre-post intervention design, we will assess improvements in QOL scores, health behaviors, and reduction of parabens in urine samples (markers of product use) of Black breast cancer survivors.

Specific Aim 3: Evaluate fidelity, feasibility, acceptability, barriers, and facilitators of the BBCSI. We will explore fidelity, feasibility, acceptability, barriers, and facilitators of intervention delivery through observation, surveys and key informant interviews with trained peer community interventionists, survivors, and community partner organizations.

The robust evidence of Black women's disproportionate exposure to carcinogenic chemicals that results in cancer-related disparities provides the impetus for this proposed intervention. I seek to fill a critical knowledge gap on developing, implementing, and analyzing community-based interventions. Dr. Teteh-Brook's strong mentorship team consists of leading experts in biological, and social influences on women's health (Glynn); randomized intervention design and implementation (Sun \& Newton); clinical implications of intervention design for Black breast cancer survivors (Brewster); and environmental exposures assessments (Dodson). The PI's long-term career goal is to become an independent, community-based implementation researcher with a focus on environmental exposure behaviors related to Black identity and the proposed K01 application will help reach this goal. This K01 will produce training and findings to support an R01 to conduct a randomized trial of the BBCSI to establish efficacy and potential for dissemination/ implementation. Dr. Teteh-Brooks will use the findings from this proposed research to further refine and develop the trial design, infrastructure, and intervention delivery procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immediate Intervention Group

Participants will be recruited through our Community Based Organizations (CBOs) and other community collaborator networks.

Group Type EXPERIMENTAL

Black Breast Cancer Survivor's Intervention

Intervention Type BEHAVIORAL

Participants will complete the BBCSI course (1-hour virtual sessions every week for 6 weeks), answer questionnaires before and after the course, and provide urine samples.

Wait-List (start in week 7)

Participants will be recruited through our Community Based Organizations (CBOs) and other community collaborator networks.

Group Type EXPERIMENTAL

Black Breast Cancer Survivor's Intervention

Intervention Type BEHAVIORAL

Participants will complete the BBCSI course (1-hour virtual sessions every week for 6 weeks), answer questionnaires before and after the course, and provide urine samples.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Black Breast Cancer Survivor's Intervention

Participants will complete the BBCSI course (1-hour virtual sessions every week for 6 weeks), answer questionnaires before and after the course, and provide urine samples.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants:

To be eligible to participate in this study, an individual must meet all the following criteria:

1. Adult women aged 18 years and older
2. Histologically confirmed stage 0-III breast cancer
3. No evidence of metastatic disease
4. Within four-years of diagnosis
5. Self-identify as Black
6. Able to communicate in English

Community Interventionists:

To be eligible to participate in this study, an individual must meet all the following criteria:

1. Adult women aged 18 years and older
2. Histologically confirmed stage 0-III breast cancer
3. No evidence of metastatic disease
4. Self-identify as Black
5. Able to communicate in English

Exclusion Criteria

1. Men or woman below 18 years of age
2. Does not have a histologically confirmed breast cancer
3. There's evidence of metastatic disease
4. More than four-years of diagnosis
5. Does not self-identify as Black
6. Unable to communicate in English
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dede Teteh-Brooks, DRPH

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dede Teteh-Brooks, DRPH

Role: CONTACT

713-563-3493

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dede Teteh-Brooks, DRPH

Role: primary

713-563-3493

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

MD Anderson Cancer Center Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2025-02122

Identifier Type: OTHER

Identifier Source: secondary_id

2024-1563

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Ghana Breast Health Study
NCT01661023 COMPLETED